Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Financial Statements Details - Accrued and Other Liabilities (Details)

v3.25.1
Condensed Consolidated Financial Statements Details - Accrued and Other Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Accrued and other liabilities    
Accrued short-term interest payable   $ 3,039
Accrued incentive compensation $ 434 1,555
Accrued clinical liabilities 26 306
Income taxes payable in connection with Pulmokine acquisition   280
Accrued legal and accounting fees 482 251
Accrued payroll and benefits 149 170
Other accrued liabilities 130 151
Total $ 1,221 $ 5,752